The susceptibilities of 284 anaerobic bacteria, including 55 strains of the Bacteroides fragilis group, were determined by an agar dilution technique to metronidazole and two newer nitroimidazoles, ornidazole and SC-28538. All three agents showed marked in vitro activity against virtually all anaerobic bacteria tested. At concentrations c1 ,ig/ml, SC-28538 was significantly more active than either rnetronidazole or ornidazole. At concentrations of >1 ,ig/ml, the activities of all three agents were comparable. Propionibacterium and Actinomyces showed significant resistance to all three agents. Anaerobic and microaerophilic members of the genus Streptococcus were also often resistant, in contrast to Peptococcus and Peptostreptococcus strains. In addition, the bactericidal activities of ornidazole and SC-28538 were determined against 27 strains of the B. fragilis group by a broth dilution technique. The minimal inhibitory and minimal bactericidal concentrations of each agent were very close. At concentrations of c0.5 jg/ml, SC-28538 showed greater bactericidal activity; at concentrations of -2 jLg/ml, the activies of both agents were similar.
The susceptibilities of 284 anaerobic bacteria, including 55 strains of the Bacteroides fragilis group, were determined by an agar dilution technique to metronidazole and two newer nitroimidazoles, ornidazole and SC-28538. All three agents showed marked in vitro activity against virtually all anaerobic bacteria tested. At concentrations c1 ,ig/ml, SC-28538 was significantly more active than either rnetronidazole or ornidazole. At concentrations of >1 ,ig/ml, the activities of all three agents were comparable. Propionibacterium and Actinomyces showed significant resistance to all three agents. Anaerobic and microaerophilic members of the genus Streptococcus were also often resistant, in contrast to Peptococcus and Peptostreptococcus strains. In addition, the bactericidal activities of ornidazole and SC-28538 were determined against 27 strains of the B. fragilis group by a broth dilution technique. The minimal inhibitory and minimal bactericidal concentrations of each agent were very close. At concentrations of c0.5 jg/ml, SC-28538 showed greater bactericidal activity; at concentrations of -2 jLg/ml, the activies of both agents were similar.
Although penicillin is the drug of choice in most non-Bacteroides fragilis anaerobic infections, a number of patients are allergic to penicillin. Both chloramphenicol and clindamycin. alternative agents active against anaerobic bacteria (including B. fragilis), produce infrequent but significant toxicity. Consequently, there is a need for the development of safe and effective antimicrobial agents for therapy of anaerobic infections.
Metronidazole was the first 5-nitroimidazole compound shown to be active in vitro against most anaerobic bacteria (10, 15, 19) . It is presently available for therapy of anaerobic infections in Europe (6, 7) and is undergoing clinical trials in the United States (8, 15 (2) . Subsequently, it was shown to be active in vitro (3, 13, 15, 19, 27) and in vivo (6) (7) (8) 15 ) against a wide variety of anaerobic bacteria. Its pharmacokinetics have been well studied previously (9, 11, 16) .
(ii) Ornidazole. Ornidazole ( Fig. 1 ) is a recently synthesized nitroimidazole derivative with antitrichomonad activity (12) . It has been previously tested and found to be active against several strains of anaerobic bacteria (20) . The pharmacokinetics (pKa, protein binding, volume of distribution, and peak serum levels) and metabolism of ornidazole are similar to those of metronidazole (11) . It is a light-yellow, crystalline substance with a melting range of 74 to 79°C. A 1% aqueous solution has a pH of approximately 6.6 . In water its solubility is 2.4% at 25°C, whereas in 95% ethanol its solubility is >50%. Ornidazole is slightly more soluble in water than metronidazole. The mean half-life of elimination from human plasma is 1.7 times greater than that of metronidazole (14.4 h for ornidazole; 8.4 h for metronidazole); this difference is statistically significant (11) .
(iii) SC-28538. SC-28538 was prepared as outlined previously (17, 18) . Its solubility in water at pH 7 is approximately 0.1%, whereas its solubility in organic ANTIMICROB. AGENTS CHEMOTHER. Ornidazole was kindly supplied by Hoffman-LaRoche and Co., Nutley, N. J., and metronidazole and SC-28538 were supplied by G. D. Searle and Co., Chicago, Ill.
Antimicrobial susceptibility tests. Minimal inhibitory concentrations (MICs) of all three agents were determined by the agar dilution method as described previously (14) . Antibiotic solutions were freshly prepared for each test, using sterilized distilled water as the solvent. In addition, 27 strains of B. fragilis were tested by a previously described twofold broth dilution method (14) for MIC and minimal bactericidal concentrations (MBCs) of ornidazole and SC-28538. B. fragilis (ATCC 29327) was used as a control organism for fast growers, and Peptococcus magnus (ATCC 29328) was used for slow growers. RESULTS Agar dilution MICs. The activities of the three drugs against the anaerobes tested are shown in Table 1 . At higher concentrations, there was little difference in the percent susceptibility, whereas at lower concentrations, there was a marked difference in percent susceptibility. At a 16-,ug/ml concentration, a level achievable in the blood with metronidazole, all 55 strains of the B. fragilis group were susceptible to all three agents. However, at 1-,ug/ml concentration, only 43. 6 and 61.8% of the strains were susceptible to metronidazole and ornidazole, respectively, whereas 94.5% were susceptible to SC-28538.
Most of the other bacteria were susceptible to metronidazole concentrations of 16 Lg/ml, including B. melaninogenicus, fusobacteria, and clostridia. Only 90.9% of Lactobacillus species and 50% of Actinomyces species tested were susceptible to metronidazole at 16 ,ug/ml. None of the five strains of anaerobic or microaerophilic streptococci and none of the four strains of Propionibacterium tested were susceptible to metronidazole at this level. The activities of ornidazole and SC-28538 at levels of 2 ,ig/ml or greater were essentially comparable to that of metronidazole for the bacteria tested. At levels of 16,ug/ml, 90.9% of Lactobacillus species were susceptible to both ormidazole and SC-28538, whereas 75 and 25% ofActinomyces species were susceptible to ornidazole and SC-28538, respectively. At the same level, all five strains of anaerobic or microaerophilic cocci were resistant to ornidazole, whereas three (60%) were susceptible to SC-28538.
Broth dilutions. The susceptibilities of 27 strains of the B. fragilis group to ornidazole and SC-28538 are illustrated in Fig. 2 . MIC and MBC curves for each agent correlated closely. The MBC was frequently one dilution greater than the MIC. At concentrations of 2 ytg/ml or greater, the activities of both agents were similar; however, at concentrations of 0.5 yg/ml or less, there was much greater activity of SC-28538. At 0.5,/g/ml, 88% of strains of B. fragilis group were inhibited (MIC) by SC-28538, whereas only 48% of strains were inhibited (MIC) by ornidazole; about 30% were killed by both drugs at this concentration.
DISCUSSION
Metronidazole has significant in vitro activity against virtually all obligate anaerobes at readily achievable blood levels (13, 20) . Previously the microaerophilic and anaerobic streptococci, Actinomyces and Propionibacterium have been reported to be resistant (13) ; our data are in agreement with those observations. Although a recent report (5) (1) .
The MIC and MBC curves for the susceptibilities of 27 strains of the B. fragilis group to ornidazole and SC-28538 were closely correlated. This correlation was comparable to that of metronidazole as reported previously (10) , where the MIC and MBC for 57 strains of B. fragilis were identical or one tube dilution apart.
Wurst (20) reported the susceptibilities of 114 strains of anaerobes to ornidazole and metronidazole. All of his strains, except seven isolates of P. acnes, were inhibited by c3.1 jig of both agents. Our data showed that a number of strains of the B. fragilis group, B. melaninogenicus, Peptococcus, Clostridium species, and Eubacterium species were not inhibited at c4 ,ig/ml.
The Propionibacterium, Actinomyces, and anaerobic and microaerophilic streptococcal strains tested also showed significant resistance to ornidazole and SC-28538. However, SC-28538 showed greater activity against the microaerophilic and anaerobic streptococci.
Both ornidazole and SC-28538 showed marked in vitro activity against virtually all anaerobes tested and may prove valuable in treatment of anaerobic infections.
